- Home
- AII vs LFCR Comparison
AII vs LFCR Comparison
Compare AII & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AII
- LFCR
- Stock Information
- Founded
- AII 2006
- LFCR 1986
- Country
- AII United States
- LFCR United States
- Employees
- AII N/A
- LFCR N/A
- Industry
- AII Property-Casualty Insurers
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- AII Finance
- LFCR Health Care
- Exchange
- AII Nasdaq
- LFCR Nasdaq
- Market Cap
- AII 370.5M
- LFCR 308.8M
- IPO Year
- AII 2025
- LFCR N/A
- Fundamental
- Price
- AII $19.96
- LFCR $7.61
- Analyst Decision
- AII Buy
- LFCR Buy
- Analyst Count
- AII 4
- LFCR 4
- Target Price
- AII $21.67
- LFCR $8.00
- AVG Volume (30 Days)
- AII 76.2K
- LFCR 106.0K
- Earning Date
- AII 08-12-2025
- LFCR 08-07-2025
- Dividend Yield
- AII N/A
- LFCR N/A
- EPS Growth
- AII N/A
- LFCR N/A
- EPS
- AII 60.71
- LFCR N/A
- Revenue
- AII $260,047,000.00
- LFCR $128,867,000.00
- Revenue This Year
- AII $25.82
- LFCR $4.78
- Revenue Next Year
- AII $25.78
- LFCR $12.02
- P/E Ratio
- AII $0.33
- LFCR N/A
- Revenue Growth
- AII 1.73
- LFCR 0.47
- 52 Week Low
- AII $15.78
- LFCR $3.68
- 52 Week High
- AII $20.30
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- AII N/A
- LFCR 53.94
- Support Level
- AII N/A
- LFCR $7.33
- Resistance Level
- AII N/A
- LFCR $7.73
- Average True Range (ATR)
- AII 0.00
- LFCR 0.30
- MACD
- AII 0.00
- LFCR 0.03
- Stochastic Oscillator
- AII 0.00
- LFCR 65.33
About AII American Integrity Insurance Group Inc. Common Stock
American Integrity Insurance Group Inc is engaged in the property and casualty insurance business. It provides personal residential property insurance for single-family homeowners and condominium owners as well as coverage for vacant dwellings and investment properties, predominantly in Florida. The Company's property and casualty insurance is currently offered in Florida, South Carolina, and Georgia.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.